Risk factors and long-term course of thyroid dysfunction during antiviral treatments in 221 patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Risk factors and long-term course of thyroid dysfunction during antiviral treatments in 221 patients with chronic hepatitis C

Published:2005-04 Issue:4 Volume:29 Page:339-345
ISSN:0399-8320
Container-title:Gastroentérologie Clinique et Biologique
language:en
Short-container-title:Gastroentérologie Clinique et Biologique

Author:

MoncouCy Xavier,Leymarie Florence,Delemer Brigitte,LÉvy Stéphane,Bernard-Chabert Brigitte,BouchÉ Olivier,Jolly Damien,Diebold Marie-Danièle,Cadiot Guillaume,ThiÉfin Gérard

Publisher

Elsevier BV

Subject

Gastroenterology,General Medicine

Reference33 articles.

1. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 malades. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hépatite C;Cacoub;Medicine (Baltimore),2000

2. High prevalence of serological markers of autoimmunity in malades with chronic hepatitis C;Clifford;Hepatology,1995

3. Hépatite C et anomalies immunologiques;Lunel;Gastroenterol Clin Biol,1994

4. Hepatitis C and D, retroviruses and autoimmune manifestations;Obermayer-Straub;J Autoimmun,2001

5. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study;Pawlotsky;Hepatology,1994

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of endocrine-related adverse events associated with interferon;Frontiers in Endocrinology;2022-08-05

2. Disfunção tireoidiana no tratamento da hepatite C com Interferon-alfa e Ribavirina;Hepatite C e tireoide;2021

3. Frequent occurrence of low-level positive autoantibodies in chronic hepatitis C;Pathology;2020-08

4. Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C;Clinical and Experimental Pediatrics;2020-02-15

5. Prevalence of thyroid stimulating hormone dysfunction among sofosbuvir-treated HCV-infected patients: A real-world clinical experience;Journal of Medical Virology;2018-10-17